Search Results - "Samantha Sartori, PhD"

Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational study by Mehran, Roxana, Prof, Baber, Usman, MD, Steg, Philippe Gabriel, Prof, Ariti, Cono, MSc, Weisz, Giora, MD, Witzenbichler, Bernhard, Prof, Henry, Timothy D, Prof, Kini, Annapoorna S, MD, Stuckey, Thomas, MD, Cohen, David J, Prof, Berger, Peter B, MD, Iakovou, Ioannis, MD, Dangas, George, Prof, Waksman, Ron, Prof, Antoniucci, David, MD, Sartori, Samantha, PhD, Krucoff, Mitchell W, Prof, Hermiller, James B, MD, Shawl, Fayaz, MD, Gibson, C Michael, Prof, Chieffo, Alaide, MD, Alu, Maria, BA, Moliterno, David J, Prof, Colombo, Antonio, Prof, Pocock, Stuart, Prof

“…Summary Background Dual antiplatelet therapy (DAPT) cessation increases the risk of adverse events after percutaneous coronary intervention (PCI). Whether risk…”
Get full text

Ticagrelor With Aspirin or Alone in High-Risk Patients After Coronary Intervention: Rationale and Design of the TWILIGHT Study by Baber, Usman, MD MS, Dangas, George, MD PhD, Cohen, David J., MD MSc, Gibson, C. Michael, MD, Mehta, Shamir, MD MSc, Angiolillo, Dominick, MD PhD, Pocock, Stuart, PhD, Krucoff, Mitchell W., MD, Kastrati, Adnan, MD, Ohman, E. Magnus, MD, Steg, Philippe Gabriel, MD, Badimon, Juan, PhD, Zafar, Urooj, PhD, Chandrasekhar, Jaya, MBBS, Sartori, Samantha, PhD, Aquino, Melissa, MS, Mehran, Roxana, MD

“…Abstract Background Dual antiplatelet therapy (DAPT) is necessary to prevent thrombosis yet increases bleeding after percutaneous coronary intervention (PCI)…”
Get full text

Safety and efficacy of drug-eluting stents in women: a patient-level pooled analysis of randomised trials by Stefanini, Giulio G, MD, Baber, Usman, MD, Windecker, Stephan, Prof, Morice, Marie-Claude, MD, Sartori, Samantha, PhD, Leon, Martin B, Prof, Stone, Gregg W, Prof, Serruys, Patrick W, Prof, Wijns, William, MD, Weisz, Giora, MD, Camenzind, Edoardo, MD, Steg, Philippe G, Prof, Smits, Pieter C, MD, Kandzari, David, MD, Von Birgelen, Clemens, MD, Galatius, Søren, MD, Jeger, Raban V, MD, Kimura, Takeshi, Prof, Mikhail, Ghada W, MD, Itchhaporia, Dipti, MD, Mehta, Laxmi, MD, Ortega, Rebecca, MHA, Kim, Hyo-Soo, MD, Valgimigli, Marco, MD, Kastrati, Adnan, Prof, Chieffo, Alaide, MD, Mehran, Roxana, Dr Prof

“…Summary Background The safety and efficacy of drug-eluting stents (DES) in the treatment of coronary artery disease have been assessed in several randomised…”
Get full text

Sex-Based Differences in Cessation of Dual-Antiplatelet Therapy Following Percutaneous Coronary Intervention With Stents by Yu, Jennifer, MBBS, Baber, Usman, MD, Mastoris, Ioannis, MD, Dangas, George, MD, PhD, Sartori, Samantha, PhD, Steg, Philippe Gabriel, MD, Cohen, David J., MD, MSc, Giustino, Gennaro, MD, Chandrasekhar, Jaya, MBBS, Ariti, Cono, MSc, Witzenbichler, Bernhard, MD, Henry, Timothy D., MD, Kini, Annapoorna S., MD, Krucoff, Mitchell W., MD, Gibson, C. Michael, MD, Chieffo, Alaide, MD, Moliterno, David J., MD, Colombo, Antonio, MD, Pocock, Stuart, PhD, Mehran, Roxana, MD

“…Abstract Objectives The aim of this study was to compare the incidence and impact of cessation of dual-antiplatelet therapy (DAPT) in women and men treated…”
Get full text

Impact of Clinical Presentation (Stable Angina Pectoris vs Unstable Angina Pectoris or Non–ST-Elevation Myocardial Infarction vs ST-Elevation Myocardial Infarction) on Long-Term Outcomes in Women Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents by Giustino, Gennaro, MD, Baber, Usman, MD, MSc, Stefanini, Giulio Giuseppe, MD, Aquino, Melissa, MSc, Stone, Gregg W., MD, Sartori, Samantha, PhD, Steg, Philippe Gabriel, MD, Wijns, William, MD, PhD, Smits, Pieter C., MD, PhD, Jeger, Raban V., MD, Leon, Martin B., MD, Windecker, Stephan, MD, PhD, Serruys, Patrick W., MD, PhD, Morice, Marie-Claude, MD, Camenzind, Edoardo, MD, Weisz, Giora, MD, Kandzari, David, MD, Dangas, George D., MD, PhD, Mastoris, Ioannis, MD, Von Birgelen, Clemens, MD, PhD, Galatius, Soren, MD, PhD, Kimura, Takeshi, MD, PhD, Mikhail, Ghada, MD, Itchhaporia, Dipti, MD, Mehta, Laxmi, MD, Ortega, Rebecca, MD, Kim, Hyo-Soo, MD, PhD, Valgimigli, Marco, MD, PhD, Kastrati, Adnan, MD, Chieffo, Alaide, MD, Mehran, Roxana, MD

“…The long-term risk associated with different coronary artery disease (CAD) presentations in women undergoing percutaneous coronary intervention (PCI) with…”
Get full text

Reply by Elze, Markus C., PhD, Gregson, John, PhD, Baber, Usman, MD, PhD, Williamson, Elizabeth, PhD, Sartori, Samantha, PhD, Mehran, Roxana, MD, PhD, Stone, Gregg W., MD, PhD, Pocock, Stuart J., PhD

Get full text

Balancing the Risk of Bleeding and Stroke in Patients With Atrial Fibrillation After Percutaneous Coronary Intervention (from the AVIATOR Registry) by Mennuni, Marco G., MD, Halperin, Jonathan L., MD, Bansilal, Sameer, MD, Schoos, Mikkel M., MD, PhD, Theodoropoulos, Kleanthis N., MD, Meelu, Omar A., MS, Sartori, Samantha, PhD, Giacoppo, Daniele, MD, Bernelli, Chiara, MD, Moreno, Pedro R., MD, Krishnan, Prakash, MD, Baber, Usman, MD, Lucarelli, Carla, MD, Dangas, George D., MD, PhD, Sharma, Samin K., MD, Kini, Annapoorna S., MD, Tamburino, Corrado, MD, PhD, Chieffo, Alaide, MD, Colombo, Antonio, MD, Presbitero, Patrizia, MD, Mehran, Roxana, MD

“…Patients with atrial fibrillation (AF) who underwent percutaneous coronary intervention (PCI) are at elevated risk for bleeding and thromboembolic ischemic…”
Get full text

Antithrombotic strategy variability in ATrial fibrillation and obstructive coronary disease revascularized with PCI—rationale and study design of the prospective observational multicenter AVIATOR 2 registry by Chandrasekhar, Jaya, MBBS, Mastoris, Ioannis, MD, Baber, Usman, MD, Sartori, Samantha, PhD, Schoos, Mikkel, MD, PhD, Bansilal, Sameer, MD, Dangas, George, MD, PhD, Mehran, Roxana, MD

“…Background In the era of novel antithrombotic therapy, the optimal treatment for patients with nonvalvular atrial fibrillation (AF) or flutter undergoing…”
Get full text

Comparison of Propensity Score Methods and Covariate Adjustment by Elze, Markus C., PhD, Gregson, John, PhD, Baber, Usman, MD, PhD, Williamson, Elizabeth, PhD, Sartori, Samantha, PhD, Mehran, Roxana, MD, PhD, Nichols, Melissa, PhD, Stone, Gregg W., MD, PhD, Pocock, Stuart J., PhD

“…Abstract Propensity scores (PS) are an increasingly popular method to adjust for confounding in observational studies. Propensity score methods have…”
Get full text

A Simple Disease-Guided Approach to Personalize ACC/AHA-Recommended Statin Allocation in Elderly People by Mortensen, Martin Bødtker, MD, PhD, Fuster, Valentin, MD, PhD, Muntendam, Pieter, MD, Mehran, Roxana, MD, Baber, Usman, MD, MS, Sartori, Samantha, PhD, Falk, Erling, MD, DMSc

“…Abstract Background The 2013 American College of Cardiology (ACC)/American Heart Association (AHA) guidelines recommend primary prevention with statins for…”
Get full text

Gender-specific outcomes after balloon aortic valvuloplasty: Inhospital and long-term outcomes by Christodoulidis, Georgios, MD, Yu, Jennifer, MD, Kini, Annapoorna, MD, Dangas, George D., MD, PhD, Baber, Usman, MD, MS, Melissa, Aquino, MS, Sartori, Samantha, PhD, Theodoropoulos, Kleanthis, MD, Bhat, Arjun, MD, Kovacic, Jason, MD, Moreno, Pedro, MD, Krishnan, Prakash, MD, Mehran, Roxana, MD, Sharma, Samin, MD

“…Background Increasing numbers of balloon aortic valvuloplasty (BAV) are performed in the management of symptomatic aortic stenosis as bridge and therapeutic…”
Get full text

Association of APOC3  Loss-of-Function Mutations With Plasma Lipids and Subclinical Atherosclerosis by Natarajan, Pradeep, MD, MMSc, Kohli, Puja, MD, Baber, Usman, MD, Nguyen, Khanh-Dung H., PhD, Sartori, Samantha, PhD, Reilly, Dermot F., PhD, Mehran, Roxana, MD, Muntendam, Pieter, PhD, Fuster, Valentin, MD, PhD, Rader, Daniel J., MD, Kathiresan, Sekar, MD

“…Coronary arterial calcification, Agatston units[dagger] 46.0 (0.0 to 245.0) 29.0 (0.0 to 227.5) -27.9 -51.1 to -4.7 0.019 Carotid plaque, mm2[dagger] 183.8…”
Get full text

Coronary Thrombosis and Major Bleeding After PCI With Drug-Eluting Stents by Baber, Usman, MD, MS, Mehran, Roxana, MD, Giustino, Gennaro, MD, Cohen, David J., MD, MSc, Henry, Timothy D., MD, Sartori, Samantha, PhD, Ariti, Cono, MSc, Litherland, Claire, MS, Dangas, George, MD, PhD, Gibson, C. Michael, MD, Krucoff, Mitchell W., MD, Moliterno, David J., MD, Kirtane, Ajay J., MD, SM, Stone, Gregg W., MD, Colombo, Antonio, MD, Chieffo, Alaide, MD, Kini, Annapoorna S., MD, Witzenbichler, Bernhard, MD, Weisz, Giora, MD, Steg, Philippe Gabriel, MD, Pocock, Stuart, PhD

“…Abstract Background Dual-antiplatelet therapy with aspirin and clopidogrel after percutaneous coronary intervention reduces the risk for coronary thrombotic…”
Get full text

Duration of Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation by Giustino, Gennaro, MD, Baber, Usman, MD, Sartori, Samantha, PhD, Mehran, Roxana, MD, Mastoris, Ioannis, MD, Kini, Annapoorna S., MD, Sharma, Samin K., MD, Pocock, Stuart J., PhD, Dangas, George D., MD, PhD

“…Abstract Background The optimal duration of dual antiplatelet therapy (DAPT) after drug-eluting stent (DES) implantation is unclear, and its risks and benefits…”
Get full text

Prevalence, Impact, and Predictive Value of Detecting Subclinical Coronary and Carotid Atherosclerosis in Asymptomatic Adults by Baber, Usman, MD, MS, Mehran, Roxana, MD, Sartori, Samantha, PhD, Schoos, Mikkel Malby, MD, PhD, Sillesen, Henrik, MD, DMSc, Muntendam, Pieter, MD, Garcia, Mario J., MD, Gregson, John, PhD, Pocock, Stuart, PhD, Falk, Erling, MD, DMSc, Fuster, Valentin, MD, PhD

“…Abstract Background Although recent studies suggest that measuring coronary artery calcification (CAC) may be superior to indirect atherosclerotic markers in…”
Get full text

Impact of body mass index on outcomes in patients undergoing transfemoral transcatheter aortic valve implantationCentral MessagePerspective by Astrid C. van Nieuwkerk, MD, Raquel B. Santos, MD, Samantha Sartori, PhD, Ander Regueiro, MD, Didier Tchétché, MD, Roxana Mehran, MD, Ronak Delewi, MD, PhD, Flavio S. De Brito, Jr., MD, PhD, Flavio Tarasoutchi, MD, Marco Barbanti, MD, Ran Kornowski, MD, Katia Orvin, MD, Azeem Latib, MD, Matteo Pagnesi, MD, Augusto D'Onofrio, MD, PhD, Giuseppe Tarantini, MD, PhD, Flavio Ribichini, MD, PhD, Mattia Lunardi, MD, Jan Baan, MD, PhD, Jan Tijssen, PhD, José P.S. Henriques, MD, PhD, Francisco Ten, Nicolas Dumonteil, MD, Angie Ghattas, MD, Paola D'Errigo, MSc, Juan Manuel Nogales, Thomas Modine, MD, George Dangas, MD, PhD

“…Objective: This study sought to investigate the effect of body mass index on outcomes in patients with severe aortic valve stenosis undergoing transcatheter…”
Get full text

Incidence, Patterns, and Associations Between Dual-Antiplatelet Therapy Cessation and Risk for Adverse Events Among Patients With and Without Diabetes Mellitus Receiving Drug-Eluting Stents by Faggioni, Michela, MD, Baber, Usman, MD, MS, Sartori, Samantha, PhD, Giustino, Gennaro, MD, Cohen, David J., MD, MSc, Henry, Timothy D., MD, Farhan, Serdar, MD, Ariti, Cono, MSc, Dangas, George, MD, PhD, Gibson, Michael, MD, Giacoppo, Daniele, MD, Krucoff, Mitchell W., MD, Aquino, Melissa, MS, Chandrasekhar, Jaya, MBBS, Moliterno, David J., MD, Colombo, Antonio, MD, Vogel, Birgit, MD, Chieffo, Alaide, MD, Kini, Annapoorna S., MD, Witzenbichler, Bernhard, MD, Weisz, Giora, MD, Steg, Philippe Gabriel, MD, Pocock, Stuart, PhD, Mehran, Roxana, MD

“…Abstract Objectives The aim of this study was to examine the frequency and clinical impact of different cessation patterns of dual-antiplatelet therapy (DAPT)…”
Get full text

Time-Dependent Associations Between Actionable Bleeding, Coronary Thrombotic Events, and Mortality Following Percutaneous Coronary Intervention by Baber, Usman, MD, MS, Dangas, George, MD, PhD, Chandrasekhar, Jaya, MBBS, Sartori, Samantha, PhD, Steg, Philippe Gabriel, MD, Cohen, David J., MD, MSc, Giustino, Gennaro, MD, Ariti, Cono, MSc, Witzenbichler, Bernhard, MD, Henry, Timothy D., MD, Kini, Annapoorna S., MD, Krucoff, Mitchell W., MD, Gibson, C. Michael, MD, Chieffo, Alaide, MD, Moliterno, David J., MD, Weisz, Giora, MD, Colombo, Antonio, MD, Pocock, Stuart, PhD, Mehran, Roxana, MD

“…Abstract Objectives The aim of this study was to examine the independent associations between actionable bleeding (AB) and coronary thrombotic events (CTE) on…”
Get full text

Correlates and Impact of Coronary Artery Calcifications in Women Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents by Giustino, Gennaro, MD, Mastoris, Ioannis, MD, Baber, Usman, MD, MSc, Sartori, Samantha, PhD, Stone, Gregg W., MD, Leon, Martin B., MD, Serruys, Patrick W., MD, PhD, Kastrati, Adnan, MD, Windecker, Stephan, MD, PhD, Valgimigli, Marco, MD, PhD, Dangas, George D., MD, PhD, Von Birgelen, Clemens, MD, Smits, Pieter C., MD, Kandzari, David, MD, Galatius, Soren, MD, Wijns, William, MD, Steg, P. Gabriel, MD, PhD, Stefanini, Giulio G., MD, PhD, Aquino, Melissa, MSc, Morice, Marie-Claude, MD, Camenzind, Edoardo, MD, Weisz, Giora, MD, Jeger, Raban V., MD, Kimura, Takeshi, MD, Mikhail, Ghada W., MD, Itchhaporia, Dipti, MD, Mehta, Laxmi, MD, Ortega, Rebecca, MD, Kim, Hyo-Soo, MD, Chieffo, Alaide, MD, Mehran, Roxana, MD

“…Abstract Objectives The aim of this study was to investigate the clinical correlates and prognostic impact of coronary artery calcification (CAC) in women…”
Get full text

Acute and 30-Day Outcomes in Women After TAVR by Chieffo, Alaide, MD, Petronio, Anna Sonia, MD, Mehilli, Julinda, MD, Chandrasekhar, Jaya, MBBS, Sartori, Samantha, PhD, Lefèvre, Thierry, MD, Presbitero, Patrizia, MD, Capranzano, Piera, MD, Tchetche, Didier, MD, Iadanza, Alessandro, MD, Sardella, Gennaro, MD, Van Mieghem, Nicolas M., MD, PhD, Meliga, Emanuele, MD, Dumonteil, Nicholas, MD, Fraccaro, Chiara, MD, PhD, Trabattoni, Daniela, MD, Mikhail, Ghada W., MD, Sharma, Samin, MD, Ferrer, Maria Cruz, MD, Naber, Christoph, MD, Kievit, Peter, MD, Faggioni, Michela, MD, Snyder, Clayton, BSc, Morice, Marie Claude, MD, Mehran, Roxana, MD

“…Abstract Objectives The study sought to examine the safety and performance of transcatheter aortic valve replacement (TAVR) using an all-female registry and to…”
Get full text